341 related articles for article (PubMed ID: 21763704)
1. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
[TBL] [Abstract][Full Text] [Related]
2. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
[TBL] [Abstract][Full Text] [Related]
3. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.
Sershen H; Hashim A; Dunlop DS; Suckow RF; Cooper TB; Javitt DC
Neurochem Res; 2016 Feb; 41(1-2):398-408. PubMed ID: 26857796
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory.
Simões PF; Silva AP; Pereira FC; Marques E; Grade S; Milhazes N; Borges F; Ribeiro CF; Macedo TR
Neuroscience; 2007 Dec; 150(2):433-41. PubMed ID: 17981398
[TBL] [Abstract][Full Text] [Related]
5. Toluene exposure during brain growth spurt and adolescence produces differential effects on N-methyl-D-aspartate receptor-mediated currents in rat hippocampus.
Chen HH; Lin YR; Chan MH
Toxicol Lett; 2011 Sep; 205(3):336-40. PubMed ID: 21726610
[TBL] [Abstract][Full Text] [Related]
6. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
8. Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.
Williams M
Biochem Pharmacol; 2009 Dec; 78(11):1360-5. PubMed ID: 19591808
[TBL] [Abstract][Full Text] [Related]
9. 5-HT(1A) and NMDA receptors interact in the rat medial septum and modulate hippocampal-dependent spatial learning.
Elvander-Tottie E; Eriksson TM; Sandin J; Ogren SO
Hippocampus; 2009 Dec; 19(12):1187-98. PubMed ID: 19309036
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
[TBL] [Abstract][Full Text] [Related]
11. Is endogenous D-serine in the rostral anterior cingulate cortex necessary for pain-related negative affect?
Ren WH; Guo JD; Cao H; Wang H; Wang PF; Sha H; Ji RR; Zhao ZQ; Zhang YQ
J Neurochem; 2006 Mar; 96(6):1636-47. PubMed ID: 16476080
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate receptors in the medial septal area have a role in spatial and emotional learning in the rat.
Elvander-Tottie E; Eriksson TM; Sandin J; Ogren SO
Neuroscience; 2006 Nov; 142(4):963-78. PubMed ID: 16952425
[TBL] [Abstract][Full Text] [Related]
13. Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats.
Morè L; Gravius A; Nagel J; Valastro B; Greco S; Danysz W
Behav Pharmacol; 2008 Oct; 19(7):724-34. PubMed ID: 18797249
[TBL] [Abstract][Full Text] [Related]
14. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
15. On the regulation of NMDA receptors by nitric oxide.
Hopper R; Lancaster B; Garthwaite J
Eur J Neurosci; 2004 Apr; 19(7):1675-82. PubMed ID: 15078541
[TBL] [Abstract][Full Text] [Related]
16. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).
Manahan-Vaughan D; Wildförster V; Thomsen C
Eur J Neurosci; 2008 Oct; 28(7):1342-50. PubMed ID: 18973561
[TBL] [Abstract][Full Text] [Related]
17. Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5.
Steele RJ; Morris RG
Hippocampus; 1999; 9(2):118-36. PubMed ID: 10226773
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
Ferraris DV; Tsukamoto T
Curr Pharm Des; 2011; 17(2):103-11. PubMed ID: 21361869
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of D-amino acid oxidase inhibitors.
Ferraris D; Duvall B; Ko YS; Thomas AG; Rojas C; Majer P; Hashimoto K; Tsukamoto T
J Med Chem; 2008 Jun; 51(12):3357-9. PubMed ID: 18507366
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.
Adage T; Trillat AC; Quattropani A; Perrin D; Cavarec L; Shaw J; Guerassimenko O; Giachetti C; Gréco B; Chumakov I; Halazy S; Roach A; Zaratin P
Eur Neuropsychopharmacol; 2008 Mar; 18(3):200-14. PubMed ID: 17681761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
